The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?

标题
The Risk of Hepatotoxicity, New Onset Diabetes and Rhabdomyolysis in the Era of High-Intensity Statin Therapy: Does Statin Type Matter?
作者
关键词
Statin, Adverse effects, Drug–drug interactions, Pharmacogenetics
出版物
PROGRESS IN CARDIOVASCULAR DISEASES
Volume 59, Issue 2, Pages 145-152
出版商
Elsevier BV
发表日期
2016-08-06
DOI
10.1016/j.pcad.2016.08.001

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started